Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.
2.

Growth hormone plus childhood low-dose estrogen in Turner's syndrome.

Ross JL, Quigley CA, Cao D, Feuillan P, Kowal K, Chipman JJ, Cutler GB Jr.

N Engl J Med. 2011 Mar 31;364(13):1230-42. doi: 10.1056/NEJMoa1005669.

3.

Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.

Zeger MP, Shah K, Kowal K, Cutler GB Jr, Kushner H, Ross JL.

Horm Res Paediatr. 2011;75(1):38-46. doi: 10.1159/000317529. Epub 2010 Aug 20.

PMID:
20733274
4.

Effect of oxandrolone and timing of oral ethinylestradiol initiation on pubertal progression, height velocity and bone maturation in the UK Turner study.

Perry RJ, Gault EJ, Paterson WF, Dunger DB, Donaldson MD.

Horm Res Paediatr. 2014;81(5):298-308. doi: 10.1159/000356924. Epub 2014 Apr 15.

PMID:
24751470
5.

Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome.

Rosenfield RL, Devine N, Hunold JJ, Mauras N, Moshang T Jr, Root AW.

J Clin Endocrinol Metab. 2005 Dec;90(12):6424-30. Epub 2005 Sep 27.

PMID:
16189255
6.

Therapy: Turner syndrome--estrogen therapy in childhood normalizes pubertal onset.

Osório J.

Nat Rev Endocrinol. 2014 Jul;10(7):379. doi: 10.1038/nrendo.2014.72. Epub 2014 May 13. No abstract available.

PMID:
24821325
7.

Individualised vs fixed dose of oral 17β-oestradiol for induction of puberty in girls with Turner syndrome: an open-randomised parallel trial.

Labarta JI, Moreno ML, López-Siguero JP, Luzuriaga C, Rica I, Sánchez-del Pozo J, Gracia-Bouthelier R; Spanish Turner working group.

Eur J Endocrinol. 2012 Oct;167(4):523-9. Epub 2012 Jul 17.

8.

CHARACTERIZATION OF SPONTANEOUS AND INDUCED PUBERTY IN GIRLS WITH TURNER SYNDROME.

Folsom LJ, Slaven JE, Nabhan ZM, Eugster EA.

Endocr Pract. 2017 Jul;23(7):768-774. doi: 10.4158/EP161738.OR. Epub 2017 Mar 23.

PMID:
28332872
9.

Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.

Quigley CA, Crowe BJ, Anglin DG, Chipman JJ.

J Clin Endocrinol Metab. 2002 May;87(5):2033-41.

PMID:
11994337
10.

Gradually increasing ethinyl estradiol for Turner syndrome may produce good final height but not ideal BMD.

Hasegawa Y, Ariyasu D, Izawa M, Igaki-Miyamoto J, Fukuma M, Hatano M, Yagi H, Goto M.

Endocr J. 2017 Feb 27;64(2):221-227. doi: 10.1507/endocrj.EJ16-0170. Epub 2016 Dec 2.

11.

Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels.

Bannink EM, van Sassen C, van Buuren S, de Jong FH, Lequin M, Mulder PG, de Muinck Keizer-Schrama SM.

Clin Endocrinol (Oxf). 2009 Feb;70(2):265-73. doi: 10.1111/j.1365-2265.2008.03446.x.

PMID:
19200215
12.

Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.

Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Zandwijken GR, de Ridder MA, Odink RJ, Jansen M, Delemarre-van de Waal HA, Stokvis-Brantsma WH, Waelkens JJ, Westerlaken C, Reeser HM, van Trotsenburg AS, Gevers EF, van Buuren S, Dejonckere PH, Hokken-Koelega AC, Otten BJ, Wit JM.

J Clin Endocrinol Metab. 2010 Mar;95(3):1151-60. doi: 10.1210/jc.2009-1821. Epub 2010 Jan 8.

PMID:
20061421
13.

Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height.

Massa G, Heinrichs C, Verlinde S, Thomas M, Bourguignon JP, Craen M, François I, Du Caju M, Maes M, De Schepper J; Belgian Study Group for Pediatric Endocrinology.

J Clin Endocrinol Metab. 2003 Sep;88(9):4168-74.

PMID:
12970282
14.

A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis.

Johnston DI, Betts P, Dunger D, Barnes N, Swift PG, Buckler JM, Butler GE.

Arch Dis Child. 2001 Jan;84(1):76-81.

15.

Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.

van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwé CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL.

J Clin Endocrinol Metab. 2003 Mar;88(3):1119-25.

PMID:
12629094
16.

Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.

Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Massa GG, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL.

J Clin Endocrinol Metab. 1999 Dec;84(12):4607-12.

PMID:
10599727
17.

Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low-birth-weight girls with early-normal onset of puberty.

Ibáñez L, Valls C, Ong K, Dunger DB, de Zegher F.

J Clin Endocrinol Metab. 2006 Jun;91(6):2068-73. Epub 2006 Feb 21.

PMID:
16492692
18.

Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients.

Carrascosa A, Gussinyé M, Terradas P, Yeste D, Audí L, Vicens-Calvet E.

J Bone Miner Res. 2000 Oct;15(10):2005-10.

19.

Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.

Massa G, Maes M, Heinrichs C, Vandeweghe M, Craen M, Vanderschueren-Lodeweyckx M.

Clin Endocrinol (Oxf). 1993 Mar;38(3):253-60.

PMID:
8458097
20.

The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome.

Ross JL, Cassorla F, Carpenter G, Long LM, Royster MS, Loriaux DL, Cutler GB Jr.

J Clin Endocrinol Metab. 1988 Sep;67(3):515-8.

PMID:
3410937

Supplemental Content

Support Center